Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

PCOS increases sexual pain and distress in infertile Iranian women.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

PCOS causes sexual dysfunction, needing comprehensive treatment.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Addressing body image and weight can help improve female sexual dysfunction.

Some medications can help increase sexual desire and function in women.

Adolescent sexual development should focus on positive aspects, including biological, psychological, and contextual factors, and recognize individual differences and the role of pleasure.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Vaginal surgeries generally did not significantly change women's sexual quality of life.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.

5α-Reductase inhibitors can negatively impact sexual function.